T cell receptor alpha variable 2 (TRAV2)

T cell receptor alpha variable 2 (TRAV2) is a gene segment encoding the variable region of the alpha chain of the αβ T cell receptor, which is expressed on the surface of T lymphocytes[1][3][5]. The T cell receptor is responsible for recognizing peptide antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells, which is a crucial event in the adaptive immune response[1][3]. The TRAV2 gene contributes to the diversity of the TCR repertoire by undergoing V-J recombination during T cell development, enabling recognition of a broad array of antigens[1][3]. Specific TRAV regions, such as TRAV12-2, can bias the antigen specificity of T cells in viral infections and immunodominant responses[2]; however, TRAV2 itself serves as a component of the variable domain enabling antigen specificity. Aberrant or engineered TCRs containing TRAV2 can play roles in autoimmunity, infection, cancer immunity, and are being explored in cellular immunotherapy, though TRAV2 is not a direct small-molecule drug target[1][2][3][5].

Other names

TCRAV11S1TCRAV2S1TRAV2TVA2

Recognition of peptide-major histocompatibility complex (pMHC) complexes on antigen-presenting cells; initiates downstream T cell signaling; not a direct drug target but critical in engineered T cell therapies (e.g., TCR-T cell therapy)[1][2][3].